Radio hyperthermia for re-treatment of superficial tumours

References

• Brown JM, Probert JC. Early and late radiation changes following a second course of irradiation. Radiology 1975; 115: 711–716
   PubMed Web of Science ®Google Scholar
• Terry NHA, Tucker SL, Travis EL. Time course and loss of residual radiation damage in murine skin assessed by retreatment. Int J Radiat Oncol Biol Phys 1989; 55: 271–283
   Google Scholar
• Stewart FA. Re-treatment after a full-course radiotherapy: Is it a viable option?. Acta Oncol 1999; 38: 855–862
   PubMed Web of Science ®Google Scholar
• Denekamp J. Residual radiation damage in mouse skin 5 to 8 months after irradiation. Radiology 1975; 115: 191–195
   PubMed Web of Science ®Google Scholar
• Wondergem J, Haveman J. The effect of previous treatment on the response of mouse feet to irradiation and hyperthermia. Radiother Oncol 1987; 10: 253–261
   PubMedGoogle Scholar
• Simmonds RH, Hopewell JW, Robbins ME. Residual radiation-induced injuries in dermal tissue: Implication for retreatment. Br J Radiol 1989; 62: 915–920
   PubMedGoogle Scholar
• Van der Kogel AJ, Sissingh HA, Zoetelief J. Effect of X-rays and neutrons on repair and regeneration in the rat spinal cord. Int J Radiat Oncol Biol Phys 1982; 8: 2095–2097
   PubMed Web of Science ®Google Scholar
• Sannazzari GL, Gabriele P, Orecchia R, Tseroni V. Results of hyperthermia, alone or combined with irradiation, in chest wall recurrences of breast cancer. Tumori 1989; 75: 284–288
   PubMed Web of Science ®Google Scholar
• Overgaard J, Gonzalez Gonzalez D, Hulshof MC, Arcangeli G, Dahl O, Mella O, Bentzen SM. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology. Lancet 1995; 345: 540–543
   PubMed Web of Science ®Google Scholar
• Valdagni R, Amichetti M. Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients. Int J Radiat Oncol Biol Phys 1994; 28: 163–169
   PubMed Web of Science ®Google Scholar
• Vernon CC, Hand JW, Field SB, Machin D, Whaley JB, Van der Zee J, Van Putten WL, Van Rhoon GC, Van Dijk JD, Gonzalez Gonzalez D, et al. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys 1996; 35: 731–744
   PubMed Web of Science ®Google Scholar
• Lepock JR. Cellular effects of hyperthermia: Relevance to the minimum dose for thermal damage. Int J Hyperthermia 2003; 19: 252–266
   PubMed Web of Science ®Google Scholar
• Overgaard J. The current and potential role of hyperthermia in radiotherapy. Int J Radiat Oncol Biol Phys 1989; 16: 535–549
   PubMed Web of Science ®Google Scholar
• Gabriele P, Orecchia R, Tseroni V, Ragona GL, Sannazzari GL. Hyperthermia alone in the treatment of recurrences of malignant tumors. Experience on 60 lesions. Cancer 1990; 66: 2191–2195
   PubMedGoogle Scholar
• Kampinga HH, Dynlacht JR, Dikomey E. Mechanism of radiosensitization by hyperthermia (>or =43°C) as derived from studies with DNA repair defective mutant cell lines. Int J Hyperthermia 2004; 20: 131–139, Review
   PubMed Web of Science ®Google Scholar
• Roca C, Primo L, Valdembri D, Cividalli A, Declerck P, Carmeliet P, Gabriele P, Bussolino F. Hyperthermia inhibits angiogenesis by a plasminogen activator inhibitor-1 dependent mechanism. Cancer Research 2003; 63: 1500–1507
   PubMed Web of Science ®Google Scholar
• Roti Roti JL, Turkel N. Heat-shock-induced changes in nuclear protein and cell killing in thermotolerant HeLa cells. Radiat Res 1994; 138: 286–290
   PubMed Web of Science ®Google Scholar
• Warters RL. Hyperthermia blocks DNA processing at the nuclear matrix. Radiat Res 1988; 115: 258–272
   PubMed Web of Science ®Google Scholar
• Song CW. Effect of local hyperthermia on blood flow and microenvironment: A review. Cancer Res 1984; 44: 4721–4730
   PubMed Web of Science ®Google Scholar
• Guiot C, Madon E, Allegro D, Pianta PG, Baiotto B, Gabriele P. Perfusion and thermal field during hyperthermia. Experimental measurements and modelling in recurrent breast cancer. Phys Med Biol 1998; 43: 2831–2843
   PubMed Web of Science ®Google Scholar
• Falk MH, Issels RD. Hyperthermia in oncology. Int J Hyperthermia 2001; 17: 1–18, Review
   PubMed Web of Science ®Google Scholar
• Jones EL, Oleson JR, Prosnitz LR, Salmuski TV, Vujaskovic Z, Yu D, Sanders LL, Dehirst MW. Randomized trial of hyperthermia and radiation for superficial tumours. J Clin Oncol 2005; 23: 3079–3085
   PubMed Web of Science ®Google Scholar
• Amichetti M, Griaff C, Fellin G, Pani G, Bolner A, Maluta S, Valdagni R. Cisplatin, Hyperthermia and radiation (trimodal therapy) in patients with locally advanced head and neck tumors: A phase I-II study. Int J Radiat Oncol Biol Phys 1993; 26: 801–807
   PubMedGoogle Scholar
• Van der Zee J, Gonzalez Gonzalez D, Van Rhoon GC, Van Dijk JD, Van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000; 355: 1119–1125
   PubMed Web of Science ®Google Scholar
• Gabriele P, Amichetti R, Orecchia R, Valdagni R, Tseroni V. Radiation therapy and hyperthermia in advanced or recurrent parotid tumors. A bi-institutional phase I-II study. Cancer 1995; 75: 908–913
   PubMed Web of Science ®Google Scholar
• Donato V, Zurlo A, Nappa M, Capua A, Banelli M, Martelli M, Gabriele P, Amichetti M, Biagini C. Multicentre experience with combined hyperthermia and radiation therapy in the treatment of superficially located non-Hodgkin's lymphomas. J Exp Clin Cancer Res 1997; 16: 87–90
   PubMedGoogle Scholar
• Sannazzari GL, Gabriele P, Orecchia R. Thermal dose and fractionation in clinical hyperthermia. Radiol Med (Torino) 1990; 79: 614–621
   PubMedGoogle Scholar
• Hand JW, Lagendijk JJW, Bach Andersen J, Bolomey JC. Quality assurance guidelines for ESHO protocols. Int J Hyperthermia 1989; 5: 421–428
   PubMed Web of Science ®Google Scholar
• Marini P, Baiotto B, Gabriele P, Guiot C. Technological improvements in MW Hyperthermia system allowing a better control of power delivering and treatment efficiency. 11th ESHO Meeting 2001. Verona. 41
   Google Scholar
• De Bruijne M, Wielheesen DHM, Van Der Zee J, Chavannes N, Van Rhoon GC. Benefits of superficial hyperthermia treatment planning: Five case studies. Int J Hyperthermia 2007; 21: 417–429
   Google Scholar
• Guiot C, Cavalli R, Gaglioti P, Danelon D, Musacchio C, Trotta M, Todros T. Temperature monitoring using ultrasound contrast agents: In vitro investigation on thermal stability. Ultrasonics 2004; 42: 927–930
   PubMedGoogle Scholar
• Gelvich EA, Mazokhin VN, Troshin II. An attempt at quantitative specification of SAR distribution homogeneity. Int J Hyperthermia 1996; 12: 431
   PubMed Web of Science ®Google Scholar
• Vaupel P, Kluge M, Ambroz MC. Laser Doppler flowmetry in subepidermal tumours and in normal skin of rats during localized ultrasound hyperthermia. Int J Hyperthermia 1988; 4: 307–321
   PubMed Web of Science ®Google Scholar
• Song CW. Effect of local hyperthermia on blood flow and microenviroment: A review. Cancer Res 1984; 44: S4721–S4730
   PubMed Web of Science ®Google Scholar
• Acker JC, Dewhirst MW, Honore GM, Samulski TV, Tucker JA, Oleson JR. Blood perfusion measurements in human tumours: Evaluation of Laser Doppler methods. Int J Hyperthermia 1990; 6: 287–304
   PubMed Web of Science ®Google Scholar
• Cox JD, Stetz JA, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group RTOG and the European Organization for Research and Treatment of Cancer EORTC. Int J Radiat Oncol Biol Phys 1995; 31: 1341–1346
   PubMed Web of Science ®Google Scholar
• Pavy JJ, Denekamp J, Letschert J, Littbrand B, Mornex F, Bernier J, Gonzales-Gonzales D, Horiot JC, Bolla M, Bartelink H. EORTC late effects working group. Late effects toxicity scoring: the SOMA scale. Int J Radiat Oncol Biol Phys 1995; 31: 1043–1047, Radiother Oncol 1995;35:11–15
   PubMed Web of Science ®Google Scholar
• Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205–216
   PubMed Web of Science ®Google Scholar
• Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481
   Web of Science ®Google Scholar
• Fowler J. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989; 62: 679
   PubMed Web of Science ®Google Scholar
• Lee AWM, Foo W, Law SCK, et al. Total biological effect on late reactive tissue following reirradiation for recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2000; 46: 865–872
   PubMedGoogle Scholar
• De Crevoisier R, Bourhis J, Domenge C. Full-dose reirradiation for unresectable head and neck carcinoma: Experience at the Gustave Roussy Institute in a series of 169 patients. J Clin Oncol 1998; 16: 3556–3562
   PubMed Web of Science ®Google Scholar
• Yan JH, Hu YM, Gu Z. Radiation therapy of recurrent nasopharyngeal carcinoma. Acta Radiol Oncol 1983; 22: 23–28
   PubMed Web of Science ®Google Scholar
• Hiraoka M, Nishimura Y, Nagata Y, Mitsumori M, Okuno Y, Li PY, Abe M, Takahashi M, Masunaga S, Akuta K, et al. Site-specific phase I, II trials of hyperthermia at Kyoto University. Int J Hyperthermia 1994; 10: 403–410, Review
   PubMed Web of Science ®Google Scholar
• Loco-regional recurrences of head and neck tumors. International workshop of otolaryngology, Turin, 5–7 March 1992, pp. 17–27, 141–149, 155–170
   Google Scholar
• Sakamoto T, Katoh H, Shimizu T, Yamashita I, Takemori S, Tazawa K, Fujimaki M. Clinical results of treatment of advanced esophageal carcinoma with hyperthermia in combination with chemoradiotherapy. Chest 1997; 112: 1487–1493
   PubMedGoogle Scholar
• Kitamura K, Kuwano H, Araki K, Egashira A, Kawaguchi H, Saeki H, Morita M, Ohno S, Sugimachi K. Clinicopathologic features of patients with oesophageal cancer obtaining a histological complete response for preoperative hyperthermo-chemo-radiotherapy. Int J Hyperthermia 1998; 14: 233–243
   PubMed Web of Science ®Google Scholar
• Kuwano H, Sumiyoshi K, Watanabe M, Sadanaga N, Nozoe T, Yasuda M, Sugimachi K. Preoperative hyperthermia combined with chemotherapy and irradiation for the treatment of patients with esophageal carcinoma. Tumori 1995; 81: 18–22
   PubMedGoogle Scholar
• Gabriele P, Baiotto B, Giovannini V, Pacetti P, Guiot C. Local hyperthermia and radiation therapy in the treatment of recurrent pretreated superficial tumors. 24th annual meeting of the European Society for Hyperthermic Oncology. PragueCzech Republique 14–16 June, 2007; 13, Abstracts
   Google Scholar